Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great impact on employees,’ CEO says

Weight-loss drugs are becoming a popular perk, with almost a third of workers saying they’d even switch jobs for it. Bank of America has them covered.

A small trial suggests a supplement containing dead bacteria could offer a cheaper alternative to weight-loss drugs such as semaglutide, but further evidence is needed

Amazon joins the federal Medicare GLP-1 Bridge Program, automating prior authorization and offering same-day delivery in more than 3,100 cities

GLP-1 drugs for weight loss are on the rise, with 11 percent of Americans saying they take one in a recent poll

Amazon Pharmacy said Thursday it has become one of the latest major providers offering the medication under a Medicare program.

UK health authorities have recorded almost 200 fatalities linked to the anti-obesity medications Mounjaro and Wegovy. These drugs have been associated with more than 150,000 adverse effects. Notably, semaglutide, which is marketed as Ozempic and Wegovy, accounts for 59 deaths, while tirzepatide, known as Mounjaro, has

Gracie McGraw reveals how Ozempic brought back her eating disorder after being prescribed the weight loss drug for her PCOS diagnosis in 2022.

The NHS GP is urging people to avoid the product after he received messages about it from followers and family members

Weight-loss medicines linked to 21% lower fracture risk in type 2 diabetes patients, a new study found, challenging assumptions that rapid weight loss inevitably raises fracture risk.

Pancreatitis — how great is the risk of weight-loss medication?  The Times

Brian Moynihan said Bank of America spends more than $250,000 on GLP-1s. Bloomberg/Getty Images Bank of America spends more than $250 million on GLP-1s for its employees. CEO Brian Moynihan said it's part of a long-term investment in employee health. GLP-1s are not only transforming corporate healthcare budgets, but a

The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.

Retatrutide — also known as "reta" — has been shown to produce dramatically greater weight loss than Ozempic and Mounjaro.

Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.

International research suggests losing weight may help people get a job - and their New Zealand counterparts say it can't be ruled out here, either.

Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safet

Jaime says TikTok taught her how to buy and inject black market peptides. Months later, she had lost 17kg.